Antibody libraries in drug and target discovery

C Rader1

  • 1Department of Molecular Biology, BCC-526 The Scripps Research Institute, 10550 North Torrey Pines Road, 92037, La Jolla, CA, USA

Drug Discovery Today
|February 13, 2001
PubMed

Insights

Antibody libraries are now mature tools for creating therapeutic monoclonal antibodies. This study highlights their use in cancer therapy for drug and target discovery.

Area of Science:

  • Biotechnology
  • Immunology
  • Oncology

Background:

  • Monoclonal antibodies (mAbs) are crucial for modern therapeutics.
  • Antibody library technology has advanced significantly.
  • Applications in cancer therapy are a key focus.

Purpose of the Study:

  • To showcase the utility of antibody libraries in drug discovery.
  • To illustrate the design, engineering, and selection of antibody libraries.
  • To emphasize applications in cancer therapy and target identification.

Main Methods:

  • Development and application of diverse antibody libraries.
  • Engineering of antibody libraries for specific therapeutic rationales.
  • Selection strategies for identifying potent therapeutic antibodies.

Main Results:

  • Demonstrated success in generating therapeutic antibodies via library approaches.
  • Examples highlight the versatility of antibody libraries in drug discovery.
  • Successful application in the context of cancer therapy.

Conclusions:

  • Antibody libraries are a powerful platform for therapeutic antibody development.
  • The presented examples underscore their value in cancer drug and target discovery.
  • Further advancements in library design and selection will enhance therapeutic applications.